Cubist Systematic Strategies, LLC Molecular Templates, Inc. Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $10,488 - $44,415	-12,949 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $29,394 - $53,479	12,949 New	12,949 $45,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $133,677 - $272,512	-39,667 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $229,275 - $311,782	39,667 New	39,667 $266,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $92,150 - $146,592	-11,784 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $109,944 - $165,565	11,784 New	11,784 $149,000
Q4 2020 Feb 16, 2021	SELL	$8.48 - $12.23 $101,420 - $146,270	-11,960 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $119,480 - $172,343	11,960 New	11,960 $131,000
Q4 2019 Feb 14, 2020	SELL	$6.44 - $14.21 $19 - $42	-3 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.6 - $8.46 $20,401 - $37,520	-4,435 Reduced 99.93%	3 $0
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $25,873 - $37,367	4,438 New	4,438 $37,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $20.9M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.